Abstract：
Robotic surgery has been increasingly adopted in various surgical fields, but the cost-effectiveness of this technology remains controversial due to its high cost and limited improvements in clinical outcomes. This study aims to explore the health economic implications of robotic pancreatic surgery, to investigate its impact on hospitalization costs and consumption of various medical resources. Data of patients who underwent pancreatic surgery at our institution were collected and divided into robotic and traditional groups. Statistical analyses of hospitalization costs, length of stay, costs across different service categories, and subgroup cost analyses based on age, BMI class, and procedure received were performed using t tests and linear regression. Although the total hospitalization cost for the robotic group was significantly higher than that for the traditional group, there was a notable reduction in the cost of medical consumables. The reduction was more prominent among elderly patients, obese patients, and those undergoing pancreaticoduodenectomy, which could be attributed to the technological advantages of the robotic surgery platform that largely facilitate blood control, tissue protection, and suturing. The study concluded that despite higher overall costs, robotic pancreatic surgery offers significant savings in medical consumables, particularly benefiting certain patient subgroups. The findings provide valuable insights into the economic viability of robotic surgery, supporting its adoption from a health economics perspective.
摘要：
机器人手术已越来越多地应用于各种手术领域，但该技术的成本效益仍存在争议,因为其成本较高,且临床结局改善有限.本研究旨在探讨机器人胰腺手术的健康经济意义。调查其对住院费用和各种医疗资源消耗的影响。收集在我们机构接受胰腺手术的患者的数据，并将其分为机器人组和传统组。住院费用的统计分析，逗留时间,不同服务类别的成本，和基于年龄的分组成本分析，BMI类，和接受的程序使用t检验和线性回归进行。尽管机器人组的总住院费用明显高于传统组，医疗耗材的成本显着降低。减少在老年患者中更为突出，肥胖患者，那些接受胰十二指肠切除术的人，这可以归因于机器人手术平台的技术优势，在很大程度上促进了血液控制，组织保护,和缝合。研究得出的结论是，尽管总体成本较高，机器人胰腺手术节省了大量医疗耗材，特别有利于某些患者亚组。这些发现为机器人手术的经济可行性提供了有价值的见解，从卫生经济学的角度支持它的采用。
